Indeed, a EWAS highlighted how the disruption of hepatic insulin signaling by DNA methylation was a leading process involved in NAFLD, with many genes showing a differential methylation and associated changes in gene expression [95] (Table 2). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.